Summary:
A 6 week randomized, multicenter study to assess the effect of the study drug on dyspeptic symptoms in diabetic patients with symptoms of diabetic gastropathy.
Qualified Participants Must:
18 - 65 years old
must be on insulin
Type I or type II diabetic
Qualified Participants May Receive:
$25 per completed visit $125 maximum for completed study